# K162955: Multi-Modality Tumor Tracking (MMTT) application

- Pathway: 510(k) (Traditional)
- Applicant: Philips Medical Systems Nederland B.V.
- Decided: Dec 19, 2016 after 56 days
- Product code: LLZ (System, Image Processing, Radiological)
- Device class: 2
- Regulation: 21 CFR 892.2050
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 10 generations back to K913770 (1991). 102 ancestors in all.
5 later devices descend from it; 2 cite it directly.
0 of 108 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K101749: Syngo Trued Software, Siemens Medical Solutions (2010) Summary page 7.
- K111336: EBW NM 2.0, Philips Medical Systems (Cleveland), Inc. (2011) Summary page 7.

## Most influential descendants
- K210831: OnQ Neuro (2021), 3 descendants of its own
- K250416: GBrain MRI (2025), 1 descendant of its own
- K252261: InferCare RECIST (2026), 0 descendants of its own
- K252362: GBrain MRI (2025), 0 descendants of its own
- K240680: CDM Insights (2024), 0 descendants of its own

## Indications for use
Multi-Modality Tumor Tracking (MMTT) application is a post processing software application used to display, process, analyze, quantify and manipulate anatomical and functional images, for CT, MR PET/CT and SPECT/CT images and/or multiple time-points. The MMTT application is intended for use on tumors which are known/confirmed to be pathologically diagnosed cancer. The results obtained may be used as a tool by clinicians in determining the diagnosis of patient disease conditions in various organs, tissues, and other anatomical structure.

Source page: https://510kreport.com/device/K162955
Methodology: https://510kreport.com/methodology
